Nolvadex-Tamoxifen Citrate Is An Anticancer Drug!

For early and advanced breast cancer in pre- and post-menopausal women, Nolvadex-Tamoxifen Citrate has been used within 10 million patients yearly. The US Food and Drug Administration (FDA) approved Nolvadex-Tamoxifen Citrate in 1998 for lessening the occurrence of breast cancer in women, which are at higher risk of developing the disease. Nolvadex-Tamoxifen Citrate is also […]